JPMorgan Chase & Co. Analysts Give Reckitt Benckiser Group (LON:RB) a GBX 8,500 Price Target

JPMorgan Chase & Co. set a GBX 8,500 ($111.05) target price on Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Wednesday, Borsen Zeitung reports.

RB has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft set a GBX 7,200 ($94.07) price target on Reckitt Benckiser Group in a report on Thursday, July 29th. The Goldman Sachs Group set a GBX 6,000 ($78.39) price objective on Reckitt Benckiser Group in a report on Thursday, September 9th. Royal Bank of Canada set a GBX 6,500 ($84.92) price objective on Reckitt Benckiser Group in a report on Tuesday, July 27th. Sanford C. Bernstein set a GBX 5,400 ($70.55) price objective on Reckitt Benckiser Group in a report on Monday, August 2nd. Finally, Barclays set a GBX 9,800 ($128.04) price objective on Reckitt Benckiser Group in a report on Wednesday, July 28th. Four research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Buy and a consensus target price of GBX 7,270 ($94.98).

The company has a fifty day simple moving average of GBX 6,356.14. The company has a current ratio of 0.77, a quick ratio of 0.53 and a debt-to-equity ratio of 116.01. Reckitt Benckiser Group has a 1-year low of GBX 5,782 ($75.54) and a 1-year high of GBX 8,020 ($104.78). The company has a market cap of £48.36 billion and a PE ratio of 40.79.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Read More: How Important is Technical Analysis of Stocks

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.